Ledger.Open graph →
SEC Form D · filed September 24, 2025

Apnimed, Inc

Offering
$23.0M
Sold
$23.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Paul C. Fonteyne · Cambridge, MADirectorBarry G. Wohl · Cambridge, MAExecDennis G. Molnar · Cambridge, MAExecRamzi C. Benamar · Cambridge, MAExecGary C. Sender · Cambridge, MADirectorChris C. Dimitropoulos · Cambridge, MADirectorFrancois C. Beaubien · Cambridge, MADirectorKevin C. Lind · Cambridge, MADirectorJoseph C. Avellone · Cambridge, MADirectorLawrence G. Miller · Cambridge, MAExec · DirectorIsaac C. Cheng · Cambridge, MADirectorLawrence G. Miller · Cambridge, MAExec · DirectorBarry G. Wohl · Cambridge, MAExecIsaac C. Cheng · Cambridge, MADirectorChris C. Dimitropoulos · Cambridge, MADirectorFrancois C. Beaubien · Cambridge, MADirectorGary C. Sender · Cambridge, MADirectorRamzi C. Benamar · Cambridge, MAExecPaul C. Fonteyne · Cambridge, MADirectorJoseph C. Avellone · Cambridge, MADirectorKevin C. Lind · Cambridge, MADirectorDennis G. Molnar · Cambridge, MAExecBrian W. Hurley · New York, NYDirectorCraig W. Ruckman · New York, NYExecTony Adams · Lenexa, KSDirectorAlan Townsend · Lenexa, KSDirectorDavid C. Owen · Lenexa, KSExecBrian Linin · Lenexa, KSDirectorRobert W. Fordi · Annapolis, MDExec · DirectorKenneth S. Code · Annapolis, MDDirectorZaiqing Zhu · New York, NYDirectorMichael L. Jones · DALLAS, TXDirectorCarl Perez · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗